title: Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
abstract: We investigated the effects of inotropic agents with phosphodiesterase III inhibitory properties, amrinone, pimobendan and vesnarinone, and cell permeable cyclic nucleotide analogue, 8-bromo adenosine 3'5'-cyclic monophosphate (8 Br-cAMP) on the induction of nitric oxide synthase (NOS) by lipopolysaccharide in J774A.1 macrophages in vitro. Although all three inotropic agents inhibited nitrite accumulation, the degree of inhibition was different, with pimobendan being the most potent inhibitor and amrinone the least. Vesnarinone inhibited nitrite formation biphasically. 8 Br-cAMP increased nitrite production at high concentrations, suggesting that the inhibitory effects of inotropic agents could not be explained by an increase in cAMP. Although differential inhibition of inducible NOS by inotropic agents may explain the different effects of these drugs in patients with heart failure, further study is necessary to reach this conclusion.
authors: Department of Cardiovascular Medicine, Kyoto University, Japan.
authors: A
authors: A
authors: Matsumori
authors: I
authors: I
authors: Okada
authors: T
authors: T
authors: Shioi
authors: Y
authors: Y
authors: Furukawa
authors: T
authors: T
authors: Nakamura
authors: K
authors: K
authors: Ono
authors: A
authors: A
authors: Iwasaki
authors: S
authors: S
authors: Sasayama
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000676:Amrinone / Q000494:pharmacology; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002460:Cell Line; D003470:Culture Media; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D051379:Mice; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D009573:Nitrites / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011719:Pyrazines; D011724:Pyridazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology
chemical_list: D002316:Cardiotonic Agents; D003470:Culture Media; D008070:Lipopolysaccharides; D009573:Nitrites; D010726:Phosphodiesterase Inhibitors; D011719:Pyrazines; D011724:Pyridazines; D011804:Quinolines; D015124:8-Bromo Cyclic Adenosine Monophosphate; C041648:pimobendan; C041667:vesnarinone; D019001:Nitric Oxide Synthase; D000676:Amrinone